Results 101 to 110 of about 15,527 (151)
Some of the next articles are maybe not open access.

SIGNIFICANCE OF THE COOMBS' TEST

Annals of Internal Medicine, 1968
Excerpt To the Editor:I read with interest the article by Bohnen and associates on the clinical significance of the Coombs' test. (Ann. Intern. Med. 68: 19, 1968).
openaire   +4 more sources

Beyond the Coombs Test

New England Journal of Medicine, 1971
The antiglobulin (Coombs) test, first applied to acquired hemolytic anemia in 1946,1 has amply proved its usefulness in helping to distinguish immune from nonimmune hemolytic disorders. This fact and the test's highly respected sensitivity may have contributed to the notion that a negative direct antiglobulin reaction in a patient with hemolytic anemia
openaire   +2 more sources

Coombs' (Antiglobulin) Test

JAMA: The Journal of the American Medical Association, 1967
The detection of antibodies against human erythrocytes is important in the diagnosis of hemolytic anemia, erythroblastosis fetalis, and transfusion reactions and is essential for crossmatching blood before transfusion. Such antibodies belong to the immunoglobulin group of proteins. The immunoglobulin-S are IgG, the most common; IgM; and IgA.
openaire   +2 more sources

In Search of a Platelet Coombs Test

New England Journal of Medicine, 1983
Between the years 1945 and 1951, two developments in the growing field of immunohematology were particularly critical. In 1945 Coombs et al. used a rabbit serum against human globulin to produce agglutination of red cells that had been sensitized by the presence of immunoglobulin on their surface.1 Before that time, there had been no dependable method ...
openaire   +2 more sources

DIRECT COOMBS TEST AND METHYLDOPA

The Lancet, 1972
Y K, Seedat, E I, Vawda
openaire   +2 more sources

The Technique of the Platelet-Coombs-Test

Acta Haematologica, 2009
P, FLUCKIGER, A, HASSIG, F, KOLLER
openaire   +2 more sources

DIRECT COOMBS TEST AND METHYLDOPA

The Lancet, 1971
C S, Chan, T K, Chan, S K, Lee
openaire   +2 more sources

Home - About - Disclaimer - Privacy